Nicholas, Timothy
Pfizer (United States)
2 papers on CoChat
Most cited papers
- Verified
The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson’s disease
Stephenson, D., Hill, D., Cedarbaum, J. M., Tome, M., Vamvakas, S., Romero, K., Conrado, D. J., Dexter, D. T., Seibyl, J., Jennings, D., et al. (2019) · Journal of Parkinson’s Disease
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 46
- Verified
Challenges in Alzheimer’s Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Conrado, D. J., Duvvuri, S., Geerts, H., Burton, J., Biesdorf, C., Ahamadi, M., Macha, S., Hather, G., Francisco Morales, J., Podichetty, J., et al. (2020) · Clinical Pharmacology & Therapeutics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free